Lisa X Xu Selected Research

Iron Overload

1/2020

Iron promotes breast cancer cell migration via IL-6/JAK2/STAT3 signaling pathways in a paracrine or autocrine IL-6-rich inflammatory environment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa X Xu Research Topics

Disease

43	Neoplasms (Cancer) 11/2023 - 01/2004
14	Neoplasm Metastasis (Metastasis) 12/2022 - 08/2009
13	Breast Neoplasms (Breast Cancer) 02/2022 - 10/2003
8	Carcinoma (Carcinomatosis) 02/2022 - 01/2007
7	Melanoma (Melanoma, Malignant) 02/2022 - 01/2017
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2012
3	Inflammation (Inflammations) 01/2020 - 10/2009
3	Hyperthermia 01/2013 - 08/2008
2	Liver Neoplasms (Liver Cancer) 11/2023 - 03/2023
2	Carcinogenesis 01/2020 - 10/2009
2	Triple Negative Breast Neoplasms 01/2020 - 01/2019
2	Dehydration (Water Stress) 01/2013 - 10/2003
2	Disease Progression 07/2010 - 08/2009
2	Lung Neoplasms (Lung Cancer) 04/2010 - 01/2008
1	Iron Overload 01/2020
1	Pathologic Processes 01/2012
1	Hepatitis 07/2011
1	Fibrosis (Cirrhosis) 07/2011
1	Fatty Liver 07/2011
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2011
1	Hepatocellular Carcinoma (Hepatoma) 07/2011
1	Ductal Carcinoma 08/2009
1	Breast Diseases (Breast Disease) 08/2009
1	Prostatic Neoplasms (Prostate Cancer) 04/2005
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2004

Drug/Important Bio-Agent (IBA)

9	Therapeutic UsesIBA 03/2023 - 02/2009
9	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2009
6	Biomarkers (Surrogate Marker)IBA 04/2014 - 08/2009
5	IronIBA 01/2020 - 07/2011
4	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2016
3	IceIBA 01/2013 - 10/2003
3	Liposomes (Liposome)IBA 05/2009 - 01/2004
2	MetalsIBA 11/2023 - 12/2004
2	NitrogenIBA 01/2022 - 01/2016
2	Deferoxamine (Desferal)FDA LinkGeneric 01/2019 - 01/2016
2	Peptides (Polypeptides)IBA 09/2012 - 05/2009
2	Contrast MediaIBA 09/2012 - 04/2010
1	RetinoidsIBA 01/2022
1	AcidsIBA 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2020
1	Oxidants (Oxidizing Agents)IBA 01/2020
1	CytokinesIBA 01/2020
1	Free RadicalsIBA 01/2020
1	Janus KinasesIBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	AntigensIBA 01/2019
1	Chelating AgentsIBA 01/2016
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2016
1	EnzymesIBA 04/2014
1	Ferrosoferric Oxide (Magnetite)FDA Link 06/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2013
1	Cysteine Proteinase InhibitorsIBA 09/2012
1	Formaldehyde (Formol)FDA Link 09/2012
1	Conditioned Culture MediaIBA 09/2012
1	Cystatin MIBA 09/2012
1	LectinsIBA 06/2012
1	Glucose (Dextrose)FDA LinkGeneric 01/2012
1	Glycocholic AcidIBA 07/2011
1	Molecular Probes (Molecular Probe)IBA 07/2011
1	Glycochenodeoxycholic Acid (Glycochenodeoxycholate)IBA 07/2011
1	ferric oxide (iron oxide)IBA 07/2011
1	Taurocholic Acid (Sodium Taurocholate)IBA 07/2011
1	ElementsIBA 07/2011
1	Chenodeoxycholic Acid (Chenix)FDA Link 07/2011
1	Bile Acids and Salts (Bile Acids)IBA 07/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2011
1	Interleukin-18 (Interleukin 18)IBA 01/2011
1	TenascinIBA 08/2009
1	ProteomeIBA 08/2009
1	Blood Proteins (Serum Proteins)IBA 08/2009
1	LigandsIBA 05/2009
1	Epidermal Growth Factor (EGF)IBA 05/2009

Therapy/Procedure

24	Therapeutics 11/2023 - 01/2007
9	Cryosurgery 01/2020 - 10/2003
4	Radiofrequency Ablation 01/2023 - 12/2013
4	Immunotherapy 12/2022 - 09/2021
3	Synchrotrons 07/2011 - 01/2008
2	Aftercare (After-Treatment) 01/2022 - 09/2013
2	Induced Hyperthermia (Thermotherapy) 01/2016 - 01/2007
2	Lasers (Laser) 08/2008 - 01/2004
1	Precision Medicine 04/2014
1	Drug Therapy (Chemotherapy) 01/2011
1	Brachytherapy 12/2004
1	Cryotherapy (Therapy, Cold) 12/2004